As we posted earlier today, Rep. Jenkins has no problem entering a lobbyist’s comments into the Congressional Record. If the rest of us did that in school or at work, I think we’d all be called out for plagarism.
From The Consumerist, a side-by-side comparison of some of the statements is illustrative:
Rep. Joe Wilson (R-SC) said: “One of the reasons I have long supported the U.S. biotechnology industry is that is is a homegrown success story that has been an engine of job creation in this country. Unfortunately, many of the largest companies that would seek to enter the biosimilar market have made their money by outsourcing their research to foreign countries like India.”
Rep. Blaine Luetkemeyer (R-MO) said: “One of the reasons I have long supported the U.S. biotechnology industry is that is is a homegrown success story that has been an engine of job creation in this country. Unfortunately, many of the largest companies that would seek to enter the biosimilar market have made their money by outsourcing their research to foreign countries like India.”
Rep. Yvette D Clarke (D-NY) said: “I see this bill as an exciting opportunity to create the kind of jobs we so desperately need in this country, while at the same time improving the lives of all Americans.”
Rep. Donald M Payne (D-NJ) said: “I see this bill as an exciting opportunity to create the kind of jobs we so desperately need in this country, while at the same time improving the lives of ALL Americans.”
Rep. K Michael Conway (R-TX) said: “I do believe the sections relating to the creation of a market for biosimilar products is one area of the bill that strikes the appropriate balance in providing lower cost options.”
Rep. Lynn Jenkins (R-KS) said: “I do believe the sections relating to the creation of a market for biosimilar products is one area of the bill that strikes the appropriate balance in providing lower cost options.”
Rep. Lee Terry (R-NE) said: “I do believe the sections relating to the creation of a market for biosimilar products is one area of the bill that strikes the appropriate balance in providing lower cost options.”
After recently not helping constituent Elizabeth Smith, voting as a member of the party of no, and sending her staff on listening tours (minus, oh, the Representative herself), what has Lynn Jenkins been doing in Washington? I’m sure her constituents would love to know.
Loading ...